Maxacalcitol

Maxacalcitol

File:Maxacalcitol Structure.svg
Clinical data
Trade names	Oxarol
Other names	22-Oxacalcitriol; OCT
Routes of administration	IV or topical
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-Hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
CAS Number	103909-75-7
PubChem CID	6398761
IUPHAR/BPS	2784
DrugBank	DB06272
ChemSpider	4911262
UNII	N2UJM5NBF6
ChEBI	CHEBI:31801
ChEMBL	ChEMBL333950
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C26H42O4
Molar mass	418.618 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@@H]([C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)(C)O
InChI InChI=1S/C26H42O4/c1-17-20(15-21(27)16-24(17)28)9-8-19-7-6-12-26(5)22(10-11-23(19)26)18(2)30-14-13-25(3,4)29/h8-9,18,21-24,27-29H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,26+/m0/s1 Key:DTXXSJZBSTYZKE-ZDQKKZTESA-N

Maxacalcitol (trade name Oxarol) is a vitamin D₃ analog and vitamin D receptor activator (VDRA). As a pharmaceutical drug, it is used as an injection to treat secondary hyperparathyroidism resulting from hemodialysis and as a topical ointment for psoriasis.

It was approved for use in Japan in 2010 and in Taiwan in 2018.